Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of $138.72 billion. The enterprise value is $183.80 billion.
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025, before market open.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Pfizer has 5.69 billion shares outstanding. The number of shares has increased by 0.97% in one year.
| Current Share Class | 5.69B |
| Shares Outstanding | 5.69B |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 67.39% |
| Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 17.64 and the forward PE ratio is 8.66.
| PE Ratio | 17.64 |
| Forward PE | 8.66 |
| PS Ratio | 2.21 |
| Forward PS | 2.26 |
| PB Ratio | 1.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.36 |
| P/OCF Ratio | 9.92 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.88, with an EV/FCF ratio of 16.38.
| EV / Earnings | 23.32 |
| EV / Sales | 2.94 |
| EV / EBITDA | 7.88 |
| EV / EBIT | 11.18 |
| EV / FCF | 16.38 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.26 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 2.55 |
| Debt / FCF | 5.56 |
| Interest Coverage | 5.57 |
Financial Efficiency
Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.
| Return on Equity (ROE) | 8.62% |
| Return on Assets (ROA) | 4.79% |
| Return on Invested Capital (ROIC) | 6.52% |
| Return on Capital Employed (ROCE) | 9.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.47 |
Taxes
| Income Tax | -510.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.37% in the last 52 weeks. The beta is 0.49, so Pfizer's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -11.37% |
| 50-Day Moving Average | 23.11 |
| 200-Day Moving Average | 26.03 |
| Relative Strength Index (RSI) | 59.28 |
| Average Volume (20 Days) | 38,156,680 |
Short Selling Information
The latest short interest is 104.99 million, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 104.99M |
| Short Previous Month | 115.16M |
| Short % of Shares Out | 1.85% |
| Short % of Float | 1.85% |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, Pfizer had revenue of $62.46 billion and earned $7.88 billion in profits. Earnings per share was $1.38.
| Revenue | 62.46B |
| Gross Profit | 46.49B |
| Operating Income | 16.45B |
| Pretax Income | n/a |
| Net Income | 7.88B |
| EBITDA | 23.32B |
| EBIT | 16.45B |
| Earnings Per Share (EPS) | $1.38 |
Full Income StatementBalance Sheet
The company has $17.32 billion in cash and $62.40 billion in debt, giving a net cash position of -$45.08 billion or -$7.93 per share.
| Cash & Cash Equivalents | 17.32B |
| Total Debt | 62.40B |
| Net Cash | -45.08B |
| Net Cash Per Share | -$7.93 |
| Equity (Book Value) | 90.64B |
| Book Value Per Share | 15.89 |
| Working Capital | 9.41B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $13.99 billion and capital expenditures -$2.77 billion, giving a free cash flow of $11.22 billion.
| Operating Cash Flow | 13.99B |
| Capital Expenditures | -2.77B |
| Free Cash Flow | 11.22B |
| FCF Per Share | $1.97 |
Full Cash Flow StatementMargins
Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.
| Gross Margin | 74.42% |
| Operating Margin | 26.33% |
| Pretax Margin | 11.82% |
| Profit Margin | 12.62% |
| EBITDA Margin | 37.34% |
| EBIT Margin | 26.33% |
| FCF Margin | 17.96% |
Dividends & Yields
This stock pays an annual dividend of $1.72, which amounts to a dividend yield of 7.05%.
| Dividend Per Share | $1.72 |
| Dividend Yield | 7.05% |
| Dividend Growth (YoY) | 2.41% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 124.35% |
| Buyback Yield | -0.97% |
| Shareholder Yield | 6.08% |
| Earnings Yield | 5.68% |
| FCF Yield | 8.09% |
Dividend DetailsAnalyst Forecast
The average price target for Pfizer is $29.92, which is 22.62% higher than the current price. The consensus rating is "Hold".
| Price Target | $29.92 |
| Price Target Difference | 22.62% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | -2.56% |
| EPS Growth Forecast (5Y) | 12.79% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on July 1, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Jul 1, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
Pfizer has an Altman Z-Score of 2.22 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.22 |
| Piotroski F-Score | 8 |